Welcome to our dedicated page for Covista news (Ticker: CVSA), a resource for investors and traders seeking the latest updates and insights on Covista stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Covista's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Covista's position in the market.
NYSE (NYSE:ICE) issued its pre-market update for Feb 24, 2026, highlighting market movers, corporate events and executive changes ahead of trading.
Key items: President Trump's 10% global levies took effect, Amer Sports reported 27% revenue growth in 2025, and AI data platform DDN named Guido Torrini as chief financial operating officer.
Covista (NYSE:ATGE) unveiled Purpose at Scale, a three-year growth plan to expand healthcare workforce capacity and AI-enabled education.
The company reported 97,000 students (up from ~76,000), 24,000 graduates last year, and provided FY26 guidance of $1.90–$1.94B revenue and $7.80–$8.00 adjusted EPS. Covista also set FY27–FY29 revenue and adjusted EPS growth targets and announced partnerships with GE Healthcare HelloAI and SAIC.